The Food and Drug Administration (FDA) released draught guidance outlining how digital health technology can be used to collect data from patients in clinical trials remotely. Sponsors, investigators, and stakeholders will find recommendations in the guidance on how to employ digital health technologies in clinical trials and how to make it easier for them to do so. The guideline covers the selection of DHTs for clinical research as well as the verification and validation.

Source: Becker’s Hospitalreview